James M Scheiman MD
Advanced Endoscopic Interventional
Professor Of Medicine, Emeritus University of Michigan
Join to View Full Profile
HomePark City, UT 84060
Dr. Scheiman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. James Scheiman is a gastroenterologist based in Park City, UT with a subspecialty in Advanced Endoscopic Interventional procedures. He completed his fellowship and residency in Gastroenterology and Internal Medicine, respectively, at the University of Michigan. Dr. Scheiman has expertise in managing biliary tract disease, gastrointestinal stromal tumors, pancreatic cancer, peptic ulcer disease, and pancreatic disease. His recent publications focus on ERCP quality and the prevention of post-ERCP pancreatitis. He has participated in clinical trials related to pancreatic cysts and esomeprazole effectiveness on peptic ulcers. Among his accolades, he is a Fellow of the ASGE, the American College of Physicians, the American Gastroenterological Association, and the American College of Gastroenterology.
Education & Training
University of MichiganFellowship, Gastroenterology, 1985 - 1987- University of MichiganResidency, Internal Medicine, 1982 - 1985
University of Michigan Medical SchoolClass of 1982
Certifications & Licensure
UT State Medical License 2022 - 2026
VA State Medical License 2017 - 2022
MI State Medical License 1983 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Fellow ASGE, 2005
- Fellow American College of Physicians, 1993
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) Start of enrollment: 2007 Feb 01
- Comparing Two Methods to Follow Patients With Pancreatic Cysts Start of enrollment: 2020 Jun 16
Publications & Presentations
PubMed
- Development and usability of an endoscopist report card assessing ERCP quality.Suqing Li, Seremi Ibadin, Christina R Studts, Susan E Jelinski, Steven J Heitman
Gastrointestinal Endoscopy. 2025-05-01 - Technical Factors Associated With the Benefit of Prophylactic Pancreatic Stent Placement During High-Risk Endoscopic Retrograde Cholangiopancreatography: A Secondary A...B Joseph Elmunzer, Jingwen Zhang, Gregory A Coté, Steven A Edmundowicz, Sachin Wani
The American Journal of Gastroenterology. 2025-04-01 - 2 citationsImpact of difficult biliary cannulation on post-ERCP pancreatitis: secondary analysis of the stent versus indomethacin trial dataset.Samuel Han, Jingwen Zhang, Valerie Durkalski-Mauldin, Lydia D Foster, Jose Serrano
Gastrointestinal Endoscopy. 2025-03-01
Journal Articles
- Randomized Trial of Switching from Prescribed Non-Selective Non-Steroidal Anti-Inflammatory Drugs to Prescribed Celecoxib: The Standard Care vs. Celecoxib Outcome Tria...James Scheiman, MD, European Heart Journal
Press Mentions
10 GI Physicians Featured in MayJune 5th, 2019
The New Face of Ulcer DiseaseJanuary 27th, 2016
For Those Who Take Painkillers Regularly, A Heartburn Pill A Day May Keep Ulcers AwayOctober 15th, 2003- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
